Sickle cell anemia is a recessive genetic disorder caused by a single point mutation in the HBB gene that swaps glutamic acid for valine in hemoglobin, making red blood cells stiffen into a sickle shape that carries oxygen poorly.
Sickle cell anemia is the classic AP Bio example of how one tiny change in DNA can have huge consequences. A single point mutation in the HBB gene swaps one amino acid (glutamic acid becomes valine) in the beta chain of hemoglobin, the protein that carries oxygen in your red blood cells.
That one swap changes a charged amino acid for a nonpolar one. The result is that when oxygen levels drop, the abnormal hemoglobin molecules clump together into long polymers. Those polymers warp the round red blood cell into a stiff, crescent (sickle) shape. Sickled cells break down easily, clog blood vessels, and carry less oxygen, which is why this single substitution causes so many downstream problems.
This term lives in Topic 5.6, Chromosomal Inheritance, but it's really the bridge term that ties together molecular genetics and inheritance patterns. It shows you the full path from genotype to phenotype: a change in DNA changes the amino acid sequence, which changes protein shape, which changes cell function. On the exam, sickle cell is the example the College Board reaches for when it wants to test whether you understand that the effect of a mutation depends on what it does to the protein, not just that a mutation happened.
Genetic Mutation (Unit 6)
Sickle cell is the textbook point mutation, a single base change that swaps one amino acid. It's the perfect counterexample to the idea that all mutations are big or all single-base changes are harmless.
Hemoglobin (Unit 4)
The mutation matters because of which protein it hits. Hemoglobin's job is carrying oxygen, so changing its shape directly cripples that function and links protein structure straight to phenotype.
Homozygous vs. Heterozygous Inheritance (Unit 5)
You only get the full disease if you're homozygous recessive. Heterozygotes have sickle cell trait, where some hemoglobin polymerizes but not enough to cause full-blown anemia, which is why carrier crosses show up in Punnett square problems.
Genetic Diversity (Unit 7)
The sickle allele persists in populations because carriers get some protection against malaria. That's natural selection maintaining a "harmful" allele, a connection to evolution that AP loves to draw.
Expect this term in two main flavors. First, molecular MCQs: a stem describes the glutamic-acid-to-valine swap and asks why one amino acid change has such dramatic effects. The answer keys on the nonpolar valine letting hemoglobin polymerize when deoxygenated. Second, inheritance and probability questions: two carrier parents (both heterozygous) have children, and you calculate the chance a given number are affected, which means combining Punnett-square ratios with probability rules. A question about heterozygotes showing roughly 40% hemoglobin polymerization is testing whether you understand that carriers have both normal and mutant alleles, so they make both proteins. Don't confuse sickle cell with chromosome-21 nondisjunction disorders like Down syndrome; sickle cell is a single gene mutation, not a whole-chromosome problem.
Both are genetic disorders, but they break in totally different ways. Sickle cell anemia comes from a single point mutation in one gene (HBB). Down syndrome comes from nondisjunction, an entire extra copy of chromosome 21. One is a typo in a single word; the other is an extra whole chapter.
Sickle cell anemia is caused by a single point mutation in the HBB gene that swaps glutamic acid for valine in hemoglobin.
That one amino acid change makes deoxygenated hemoglobin polymerize, which sickles the red blood cell and reduces oxygen transport.
The disorder is recessive, so you need two copies of the allele (homozygous recessive) to have full sickle cell anemia.
Heterozygotes have sickle cell trait, making both normal and abnormal hemoglobin, and are usually only mildly affected.
The sickle allele stays common in populations because carriers resist malaria, a classic example of natural selection maintaining diversity.
Sickle cell is a single-gene mutation, completely different from chromosome-number disorders like Down syndrome caused by nondisjunction.
It's a recessive genetic disorder caused by a point mutation in the HBB gene that changes glutamic acid to valine in hemoglobin. AP Bio uses it as the model for how one base change can deform a protein and disrupt cell function.
Because valine is nonpolar while glutamic acid is charged, the swap lets hemoglobin molecules stick together into polymers when oxygen is low. Those polymers force the red blood cell into a stiff sickle shape that clogs vessels and carries oxygen poorly.
Recessive. You need two copies of the allele (homozygous recessive) to have the disease. People with one copy (heterozygous) have sickle cell trait and make both normal and mutant hemoglobin.
Sickle cell comes from a single point mutation in one gene, the HBB gene. Down syndrome comes from nondisjunction, an extra whole copy of chromosome 21. One is a single-letter typo; the other is an extra chromosome.
Each carrier is heterozygous, so a cross gives a 1/4 chance of an affected (homozygous recessive) child. For questions asking about a specific number of affected kids out of several, combine that 1/4 ratio with probability rules like the binomial approach.